Biolojic presented the first ever preclinical data on a multibody-drug conjugate, BD200, at the AACR 2026 | Biolojic Design

Categories: News | Published On: April 19, 2026 | Written by webadmin@biolojic.com |

Biolojic presented the first ever preclinical data on a multibody-drug conjugate, BD200, at the AACR 2026

More News

New Technical Report: Biolojic Design’s AI-Powered Platform Enables Systematic Engineering of Dual-Specific ‘Two-in-One’ IgG Antibodies (Multibodies) Against Any Target Pair
Read More
Biolojic Design Appoints Roger Waltzman as Chief Medical Officer
Read More

BUSINESS AND MEDIA INQUIRIES

Micah Pearlman
micah@biolojic.com